MRES (Institute of Biomedical Research) Piotroski F-Score: 0 (As of Jun. 26, 2026)


What is Institute of Biomedical Research Piotroski F-Score?

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Institute of Biomedical Research has an F-score of 2. It is a bad or low score, which usually implies poor business operation.

The historical rank and industry rank for Institute of Biomedical Research's Piotroski F-Score or its related term are showing as below:

Institute of Biomedical Research  (OTCPK:MRES) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Institute of Biomedical Research Piotroski F-Score Related Terms


Institute of Biomedical Research Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for Institute of Biomedical Research's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Institute of Biomedical Research Piotroski F-Score Chart

Institute of Biomedical Research Annual Data
Trend Dec03 Dec04 Mar06 Mar07 Mar08 Mar09 Mar10
Piotroski F-Score
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Institute of Biomedical Research Quarterly Data
Mar06 Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec10) TTM:Last Year (Dec09) TTM:
Net Income was -0.119 + -50.082 + -0.077 + -0.056 = $-50.33 Mil.
Cash Flow from Operations was -0.092 + -0.031 + -0.023 + -0.005 = $-0.15 Mil.
Revenue was 0 + 0 + 0 + 0 = $0.00 Mil.
Gross Profit was 0 + 0 + 0 + 0 = $0.00 Mil.
Average Total Assets from the begining of this year (Dec09)
to the end of this year (Dec10) was
(0.075 + 0.076 + 0.68 + 0.668 + 0.655) / 5 = $0.4308 Mil.
Total Assets at the begining of this year (Dec09) was $0.08 Mil.
Long-Term Debt & Capital Lease Obligation was $0.00 Mil.
Total Current Assets was $0.00 Mil.
Total Current Liabilities was $0.46 Mil.
Net Income was -0.15 + -0.032 + -0.021 + -0.102 = $-0.31 Mil.

Revenue was 0 + 0 + 0 + 0 = $0.00 Mil.
Gross Profit was 0 + 0 + 0 + 0 = $0.00 Mil.
Average Total Assets from the begining of last year (Dec08)
to the end of last year (Dec09) was
(0.084 + 0.078 + 0.071 + 0.065 + 0.075) / 5 = $0.0746 Mil.
Total Assets at the begining of last year (Dec08) was $0.08 Mil.
Long-Term Debt & Capital Lease Obligation was $0.00 Mil.
Total Current Assets was $0.00 Mil.
Total Current Liabilities was $0.30 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Institute of Biomedical Research's current Net Income (TTM) was -50.33. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Institute of Biomedical Research's current Cash Flow from Operations (TTM) was -0.15. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Dec09)
=-50.334/0.075
=-671.12

ROA (Last Year)=Net Income/Total Assets (Dec08)
=-0.305/0.084
=-3.63095238

Institute of Biomedical Research's return on assets of this year was -671.12. Institute of Biomedical Research's return on assets of last year was -3.63095238. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Institute of Biomedical Research's current Net Income (TTM) was -50.33. Institute of Biomedical Research's current Cash Flow from Operations (TTM) was -0.15. ==> -0.15 > -50.33 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Dec10)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec09 to Dec10
=0/0.4308
=0

Gearing (Last Year: Dec09)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec08 to Dec09
=0/0.0746
=0

Institute of Biomedical Research's gearing of this year was 0. Institute of Biomedical Research's gearing of last year was 0. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Dec10)=Total Current Assets/Total Current Liabilities
=0/0.461
=0

Current Ratio (Last Year: Dec09)=Total Current Assets/Total Current Liabilities
=0/0.301
=0

Institute of Biomedical Research's current ratio of this year was 0. Institute of Biomedical Research's current ratio of last year was 0. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Institute of Biomedical Research's number of shares in issue this year was 66.281. Institute of Biomedical Research's number of shares in issue last year was 5.401. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=0/0
=

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=0/0
=

Institute of Biomedical Research's gross margin of this year was . Institute of Biomedical Research's gross margin of last year was . ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Dec09)
=0/0.075
=0

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Dec08)
=0/0.084
=0

Institute of Biomedical Research's asset turnover of this year was 0. Institute of Biomedical Research's asset turnover of last year was 0. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+0+0+1+1+0+0+0+0
=2

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Institute of Biomedical Research has an F-score of 2. It is a bad or low score, which usually implies poor business operation.


Institute of Biomedical Research Business Description

Address Dubai Science Park, 13th Floor, South Tower, Dubai, ARE, 416452
Institute of Biomedical Research Corp is a biomedical research and development company. The company is focused on alternative plant-based food and medicine and mental health therapeutic research. The company uses brand name M2Bio Sciences engaged in deploying artificial intelligence, science and medicine, clinical research, and emerging technologies.